Organizations Employees Board Members Grants Contractors Top Rankings Pricing

Stay updated on 990 organization compensation

© 2026 Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices

Employees Foundation for Angelman Syndrome Therapeutics Kena Pearson

Kena Pearson

Officer

Chief Financial Officer at Foundation for Angelman Syndrome Therapeutics

Fiscal year ended December 31, 2024. Published on January 25, 2026.

$232,568

2024

Total compensation

Kena Pearson has been listed as an employee of Foundation for Angelman Syndrome Therapeutics in Form 990 filings since fiscal year 2024.

Annual compensation details

$232,568

Chief Financial Officer

2024

$233k org

40 hrs/wk

Total compensation by year

Compare the compensation of Kena Pearson to:

2024

Other employees at Foundation for Angelman Syndrome Therapeutics

Chief Science Officer

$0 from org$509,945 from relatedNo other comp

Chief Operating Oficer

$286,130 from orgNo related compNo other comp

President and Chief Executive Officer

$245,000 from orgNo related compNo other comp

Michele Golombuski

Chief Development Officer

$210,068 from orgNo related compNo other comp

Loading rankings…

Loading related profiles…

Revisions to this profile

January 25, 2026:

2024 Foundation for Angelman Syndrome Therapeutics 990 published

Get an email update when compensation for Kena Pearson is updated

Email address

Related Jobs

Powered by Talroo

Report a discrepancy →